Oscar Health
OSCR
330 hedge funds and large institutions have $2.01B invested in Oscar Health in 2026 Q1 according to their latest regulatory filings, with 63 funds opening new positions, 118 increasing their positions, 101 reducing their positions, and 67 closing their positions.
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
17% more repeat investments, than reductions
Existing positions increased: 118 | Existing positions reduced: 101
3% less call options, than puts
Call options by funds: $165M | Put options by funds: $170M
6% less first-time investments, than exits
New positions opened: 63 | Existing positions closed: 67
3% less funds holding
Funds holding: 341 → 330 (-11)
7.04% less ownership
Funds ownership: 73.59% → 66.55% (-7%)
17% less capital invested
Capital invested by funds: $2.42B → $2.01B (-$416M)
Top Buyers
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$48.7M |
| 2 |
Jane Street
New York
|
-$40.5M |
| 3 |
Two Sigma Investments
New York
|
-$26.1M |
| 4 |
Millennium Management
New York
|
-$16.5M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$11.9M |
OSCR Hedge Fund Activity: Q1 2026 in Review
330 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Oscar Health (OSCR) for Q1 2026, worth a combined $2.01B — down 17% from $2.42B a quarter earlier.
Sellers outnumbered buyers: 67 funds closed out of OSCR and 63 opened new positions — a net loss of 4 holders — while 101 trimmed existing stakes and 118 added.
The largest buyer was T. Rowe Price Investment Management, adding an estimated $34.2M. The largest seller was Morgan Stanley, cutting an estimated $48.7M.
- 330 institutional investors held Oscar Health (OSCR) as of Q1 2026, down from 341 in Q4 2025.
- Funds reported $2.01B of Oscar Health stock for Q1 2026, down 17% quarter-over-quarter.
- 63 funds opened new Oscar Health positions in Q1 2026 and 67 closed out, a net change of -4 holders.
- The largest Oscar Health buyer in Q1 2026 was T. Rowe Price Investment Management, an estimated $34.2M added.
- The largest Oscar Health seller in Q1 2026 was Morgan Stanley, an estimated $48.7M sold.
Based on aggregated 13F filings for Q1 2026.